There's actually more that you can know, by researching for yourself.
Former HHS leaders argued the drug rule would benefit patients who struggle to pay for expensive insulin and allergy medication. However, the health centers said they already pass on those savings and this rule is merely an administrative burden that paints them as entities that price-gouge patients. It’s not clear how many facilities would have to follow the rule or face funding restrictions.
There's actually more that you can know, by researching for yourself.
They do price gouge their customers/patients
Which also makes insurance waaay more expensive.
Yeah, I'll say it: it's easier to protect preexisting conditions if life saving drugs are priced more appropriately to the cost of production.